Biomedicine. Back to an aspirin a day?

Science. 2002 Apr 19;296(5567):474-5. doi: 10.1126/science.1071702.
No abstract available

Publication types

  • Comment
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Carotid Artery Injuries / pathology
  • Cell Division
  • Clinical Trials as Topic
  • Cyclooxygenase 1
  • Cyclooxygenase 2
  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors / adverse effects*
  • Cyclooxygenase Inhibitors / pharmacology
  • Cyclooxygenase Inhibitors / therapeutic use
  • Epoprostenol / metabolism*
  • Homeostasis
  • Humans
  • Isoenzymes / antagonists & inhibitors
  • Lactones / adverse effects*
  • Lactones / pharmacology
  • Lactones / therapeutic use
  • Membrane Proteins
  • Mice
  • Muscle, Smooth, Vascular / cytology
  • Myocardial Infarction / epidemiology
  • Naproxen / therapeutic use
  • Platelet Activation / drug effects*
  • Prostaglandin-Endoperoxide Synthases
  • Receptors, Epoprostenol
  • Receptors, Prostaglandin / genetics
  • Receptors, Prostaglandin / metabolism
  • Receptors, Thromboxane / genetics
  • Receptors, Thromboxane / metabolism
  • Sulfones
  • Thromboxane A2 / metabolism*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors
  • Isoenzymes
  • Lactones
  • Membrane Proteins
  • Receptors, Epoprostenol
  • Receptors, Prostaglandin
  • Receptors, Thromboxane
  • Sulfones
  • rofecoxib
  • Thromboxane A2
  • Naproxen
  • Epoprostenol
  • Cyclooxygenase 1
  • Cyclooxygenase 2
  • PTGS1 protein, human
  • PTGS2 protein, human
  • Prostaglandin-Endoperoxide Synthases
  • Ptgs1 protein, mouse